HIGH ALERT: Please review policy carefully.
potassium chloride
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPSULE, EXTENDED RELEASE, ORAL | 8 mEq | non formulary | ||||||||||
| LIQUID, ORAL | 20 mEq/15 mL | |||||||||||
| POWDER FOR RECONSTITUTION, ORAL | 20 mEq | |||||||||||
| SOLUTION, INTRAVENOUS | 2 mEq/mL; 10 mEq/50 mL; 10 mEq/100 mL; 20 mEq/50 mL; 20 mEq/100 mL; 40 mEq/100 mL | |||||||||||
| TABLET, EXTENDED RELEASE, ORAL | 8 mEq; 10 mEq; 20 mEq | Nonformulary |
Potassium extended release (microencapsulated) tablets (Klor Con M) are formulary.
Potassium chloride wax matrix tablets are non-formulary.
potassium chloride